Synthesis and anti-HCV activity of a new 2′-deoxy-2′-fluoro-2′-C-methyl nucleoside analogue
- 22 October 2010
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 20 (24) , 7297-7298
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- An Efficient and Diastereoselective Synthesis of PSI-6130: A Clinically Efficacious Inhibitor of HCV NS5B PolymeraseThe Journal of Organic Chemistry, 2009
- The design of drugs for HIV and HCVNature Reviews Drug Discovery, 2007
- Epidemiology of hepatitis C virus infectionWorld Journal of Gastroenterology, 2007
- Design, Synthesis, and Antiviral Activity of 2‘-Deoxy-2‘-fluoro-2‘-C-methylcytidine, a Potent Inhibitor of Hepatitis C Virus ReplicationJournal of Medicinal Chemistry, 2005
- Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA ReplicationJournal of Medicinal Chemistry, 2004
- Synthesis of Potentially Antiviral 2′,3′-Dideoxy-2′-fluoro-3′-(hydroxyamino)nucleosidesHelvetica Chimica Acta, 2004
- Viral hepatitis CThe Lancet, 2003
- Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside AnalogsJournal of Biological Chemistry, 2003
- Natural history of hepatitis C: Its impact on clinical managementHepatology, 2000
- Hepatitis C: progress and problemsClinical Microbiology Reviews, 1994